These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 25255392

  • 1. Endothelin A receptor blocker atrasentan lowers blood pressure by the reduction of nifedipine-sensitive calcium influx in Ren-2 transgenic rats fed a high-salt diet.
    Vaněčková I, Dobešová Z, Kuneš J, Vernerová Z, Zicha J.
    J Hypertens; 2015 Jan; 33(1):161-9. PubMed ID: 25255392
    [Abstract] [Full Text] [Related]

  • 2. Moderate additive effects of endothelin receptor A blockade in Ren-2 transgenic rats subjected to various types of RAS blockade.
    Vaněčková I, Řezáčová L, Kuneš J, Zicha J.
    Life Sci; 2016 Aug 15; 159():127-134. PubMed ID: 26775568
    [Abstract] [Full Text] [Related]

  • 3. Distinct effects of bosentan on NO-dependent vasodilation and calcium influx in heterozygous Ren-2 transgenic rats on high-salt diet.
    Vaněčková I, Hojná S, Kadlecová M, Kompanowska-Jezierska E, Zicha J.
    Physiol Res; 2019 Oct 25; 68(5):717-725. PubMed ID: 31424254
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Vasodilator efficiency of endogenous prostanoids, Ca²⁺-activated K⁺ channels and nitric oxide in rats with spontaneous, salt-dependent or NO-deficient hypertension.
    Behuliak M, Pintérová M, Kuneš J, Zicha J.
    Hypertens Res; 2011 Aug 25; 34(8):968-75. PubMed ID: 21818109
    [Abstract] [Full Text] [Related]

  • 6. The altered balance between sympathetic nervous system and nitric oxide in salt hypertensive Dahl rats: ontogenetic and F2 hybrid studies.
    Dobesová Z, Kunes J, Zicha J.
    J Hypertens; 2002 May 25; 20(5):945-55. PubMed ID: 12011656
    [Abstract] [Full Text] [Related]

  • 7. Blockade of endothelin receptors attenuates end-organ damage in homozygous hypertensive ren-2 transgenic rats.
    Dvorák P, Kramer HJ, Bäcker A, Malý J, Kopkan L, Vanecková I, Vernerová Z, Opocenský M, Tesar V, Bader M, Ganten D, Janda J, Cervenka L.
    Kidney Blood Press Res; 2004 May 25; 27(4):248-58. PubMed ID: 15286437
    [Abstract] [Full Text] [Related]

  • 8. End-organ damage in hypertensive transgenic Ren-2 rats: influence of early and late endothelin receptor blockade.
    Vernerová Z, Kujal P, Kramer HJ, Bäcker A, Cervenka L, Vaneckova I.
    Physiol Res; 2009 May 25; 58 Suppl 2():S69-S78. PubMed ID: 20131938
    [Abstract] [Full Text] [Related]

  • 9. Late-onset endothelin-A receptor blockade reduces podocyte injury in homozygous Ren-2 rats despite severe hypertension.
    Opocenský M, Kramer HJ, Bäcker A, Vernerová Z, Eis V, Cervenka L, Certíková Chábová V, Tesar V, Vanecková I.
    Hypertension; 2006 Nov 25; 48(5):965-71. PubMed ID: 17015777
    [Abstract] [Full Text] [Related]

  • 10. Vasoactive systems in L-NAME hypertension: the role of inducible nitric oxide synthase.
    Pechánová O, Dobesová Z, Cejka J, Kunes J, Zicha J.
    J Hypertens; 2004 Jan 25; 22(1):167-73. PubMed ID: 15106808
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Role of angiotensin II in chronic blood pressure control of heterozygous Ren-2 transgenic rats: Peripheral vasoconstriction versus central sympathoexcitation.
    Řezáčová L, Hojná S, Kopkan L, Rauchová H, Kadlecová M, Zicha J, Vaněčková I.
    Biomed Pharmacother; 2019 Aug 25; 116():108996. PubMed ID: 31132670
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Late-onset endothelin receptor blockade in hypertensive heterozygous REN-2 transgenic rats.
    Vernerová Z, Kramer HJ, Bäcker A, Cervenka L, Opocenský M, Husková Z, Vanourková Z, Eis V, Chábová VC, Tesar V, Malý J, Vanecková I.
    Vascul Pharmacol; 2008 Aug 25; 48(4-6):165-73. PubMed ID: 18372220
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.